Challenges to innovative drug discovery by academia in Japan: Strategies to solve difficulties

被引:0
|
作者
Suzuki-Nishimura, Tamiko [1 ]
机构
[1] Shujitsu Univ, Sch Pharm, Naka Ku, Okayama 7038516, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:30P / 30P
页数:1
相关论文
共 50 条
  • [21] The Urban Planning Strategies to Solve the Parking Difficulties in Harbin
    Lv, Fei
    Qi, Xiaochen
    ARCHITECTURE, BUILDING MATERIALS AND ENGINEERING MANAGEMENT, PTS 1-4, 2013, 357-360 : 1612 - 1616
  • [22] Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them
    Sosnik, Alejandro
    Augustine, Robin
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 103 : 105 - 120
  • [23] A bridge between academia and the drug discovery pipeline
    Alan Gibson
    Nature Reviews Drug Discovery, 2002, 1 : 401 - 401
  • [24] Drug discovery in academia: A successful case study
    Jung, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [25] A bridge between academia and the drug discovery pipeline
    Gibson, A
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (05) : 401 - 401
  • [26] Academia-industry partnerships in drug discovery
    Dalrymple, Michael
    Taylor, Debbie
    Kettleborough, Catherine
    Bryans, Justin
    Solari, Roberto
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (01) : 1 - 6
  • [27] How academia can help drug discovery
    Simon Frantz
    Nature Reviews Drug Discovery, 2004, 3 (7) : 541 - 541
  • [28] Drug discovery in academia: A student's perspective
    Smith, Breland E.
    Hulme, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [29] Open innovation network for drug development and drug discovery in academia
    Ichijo, Hidenori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S48 - S48
  • [30] The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets
    Altamura, Fernando
    Rajesh, Rishi
    Catta-Preta, Carolina M. C.
    Moretti, Nilmar S.
    Cestari, Igor
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (02) : 225 - 252